Diabetes Drug Developer Hua Is Said to Pick Hong Kong for IPO

(Bloomberg) -- Hua Medicine Ltd., a Shanghai-based developer of diabetes drugs, has picked Hong Kong over the U.S. for its initial public offering as the Asian financial hub makes a push for biotec...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.